Khiron Life Sciences Corp.
$0.00+0.00%(+$0.00)
TickerSpark Score
58/100
87
Valuation
30
Profitability
60
Growth
84
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KHRNF research report →
52-Week Range100% of range
Low $0.00
Current $0.00
High $0.00
Companykhiron.ca
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments.
- CEO
- Alvaro Francisco Torres
- IPO
- 2021
- Employees
- 310
- HQ
- Vancouver, BC, CA
Price Chart
+0.00% · this period
Valuation
- Market Cap
- $2.32K
- P/E
- -0.20
- P/S
- 0.73
- P/B
- 0.20
- EV/EBITDA
- -0.12
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 22.47%
- Op Margin
- -174.52%
- Net Margin
- -258.92%
- ROE
- -68.62%
- ROIC
- -61.04%
Growth & Income
- Revenue
- $12.79M · 59.60%
- Net Income
- $-33,129,000 · -37.81%
- EPS
- $-0.20 · 0.00%
- Op Income
- $-19,787,000
- FCF YoY
- 18.66%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 5.43
- Avg Volume
- 25.03K
Get TickerSpark's AI analysis on KHRNF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our KHRNF Coverage
We haven't published any research on KHRNF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate KHRNF Report →